Ligand · 87E
87E · (2S)-2-[[(2R)-2-[(2R,3R,4R,5S,6R)-3-acetamido-2-[[[(2R, 3S,4R,5R)-5-[2,4-bis(oxidanylidene)pyrimidin-1-yl]-3, 4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxy-6-(hydroxymethyl)-5-oxidanyl-oxan-4-yl]oxypropanoyl]amino]-3-oxidanyl-propanoic acid
87E, (2S)-2-[[(2R)-2-[(2R,3R,4R,5S,6R)-3-acetamido-2-[[[(2R, 3S,4R,5R)-5-[2,4-bis(oxidanylidene)pyrimidin-1-yl]-3, 4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxy-6-(hydroxymethyl)-5-oxidanyl-oxan-4-yl]oxy…
- Component
- 87E
- Formula
- C23 H36 N4 O21 P2
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
87E in 2 structures; the first of them:
- 7W1G · Crystal structure of YfiH with C107A mutation in complex with UDP-MurNAc-L-Serine · 87E C301 · binds GLN69, HIS71, MET103, THR104, ALA105, ASP106, ALA107, HIS124 and 15 more
- 7W1G · Crystal structure of yfih with C107A mutation in complex with udp- murnac-L-serine · 87E C301 · binds GLN69, HIS71, MET103, THR104, ALA105, ASP106, ALA107, HIS124 and 14 more
Residues it binds most
ARG 4, ALA 4, GLY 4, HIS 4, VAL 4, GLU 4, ILE 4, ASP 4, GLN 4, LYS 4 (residue and the binding sites it lines).
Found with
- EPZ · (2R)-2-{[(2R,3R,4R,5S,6R)-3-(acetylamino)-2-{[(S)-{[(R)-{[(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methoxy}(hydroxy) phosphoryl]oxy}(hydroxy)phosphoryl]oxy}-5-hydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl]oxy}propanoic acid
- SO4 · Sulfate ion
- ACT · Acetate ion
- TRS · 2-amino-2-hydroxymethyl-propane-1,3-diol
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.